Loading…

Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection

Background and Aim The esophageal triamcinolone acetonide (TA)‐filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential ESD. Methods We enrolled 20 patients with esophageal ca...

Full description

Saved in:
Bibliographic Details
Published in:Digestive endoscopy 2020-03, Vol.32 (3), p.355-363
Main Authors: Shibagaki, Kotaro, Yuki, Takafumi, Taniguchi, Hideaki, Aimi, Masahito, Miyaoka, Yoichi, Yuki, Mika, Ishimura, Norihisa, Oshima, Naoki, Mishiro, Tsuyoshi, Tamagawa, Yuji, Mikami, Hironobu, Izumi, Daisuke, Yamashita, Noritsugu, Sato, Shuichi, Ishihara, Shunji, Kinoshita, Yoshikazu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023
cites cdi_FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023
container_end_page 363
container_issue 3
container_start_page 355
container_title Digestive endoscopy
container_volume 32
creator Shibagaki, Kotaro
Yuki, Takafumi
Taniguchi, Hideaki
Aimi, Masahito
Miyaoka, Yoichi
Yuki, Mika
Ishimura, Norihisa
Oshima, Naoki
Mishiro, Tsuyoshi
Tamagawa, Yuji
Mikami, Hironobu
Izumi, Daisuke
Yamashita, Noritsugu
Sato, Shuichi
Ishihara, Shunji
Kinoshita, Yoshikazu
description Background and Aim The esophageal triamcinolone acetonide (TA)‐filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential ESD. Methods We enrolled 20 patients with esophageal cancer requiring subcircumferential ESD in a prospective multicenter study. Esophageal TA filling was carried out 1 day and 1 week after ESD, with follow‐up endoscopy every 2 weeks. We treated severe stenosis preventing endoscope passage with endoscopic balloon dilatation (EBD) and additional TA filling, and mild stenosis allowing endoscope passage with additional TA filling only. Primary endpoint was incidence of severe stenosis; secondary endpoints were total number of EBD, rate of additional TA filling, time to stenosis and complete re‐epithelialization, dysphagia score, and adverse events. Horizontal resection grade was divided into grades 1 (≥ 9/12 and
doi_str_mv 10.1111/den.13496
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2267406172</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2267406172</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023</originalsourceid><addsrcrecordid>eNp1kcFuFSEUhonR2NvqwhcwLHUx7QADU5amVmvStF3oeoKHQy-GgXFgbO7OR_AxfC6fRMZbGzeyOCQnH18O5yfkBWuPWT0nFuMxE51Wj8iGdZ1omFLsMdm0mslGKiEPyGHOX9qWcd11T8mBYEIxzeWG_LyZU54Qiv-GdFxC8YCx4ExzWeyOJkfLFinmNG3NLZpAy-zNCD6mkCJSA1hS9BZ_ff_hfAg-3tIRyzZZ6iOdTPHVlumdL1ual8_gZ1hGh3Pt-ir7x4vRpgxp8rCC4wIp1671Oa_DpfiMPHEmZHx-fx-RT-_OP55dNJfX7z-cvblsYF1Aw512pwY406rlguMpgJa670UvpBMOnJEKmTbM1uJ6roXsraxFgWuhPjkir_beaU5fF8xlGH0GDMFETEseOFd91yrWr-jrPQp1h3lGN0yzH828G1g7rMEMNZjhTzCVfXmvrZ9D-0D-TaICJ3vgzgfc_d80vD2_2it_A993ngA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2267406172</pqid></control><display><type>article</type><title>Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection</title><source>Wiley-Blackwell Journals</source><creator>Shibagaki, Kotaro ; Yuki, Takafumi ; Taniguchi, Hideaki ; Aimi, Masahito ; Miyaoka, Yoichi ; Yuki, Mika ; Ishimura, Norihisa ; Oshima, Naoki ; Mishiro, Tsuyoshi ; Tamagawa, Yuji ; Mikami, Hironobu ; Izumi, Daisuke ; Yamashita, Noritsugu ; Sato, Shuichi ; Ishihara, Shunji ; Kinoshita, Yoshikazu</creator><creatorcontrib>Shibagaki, Kotaro ; Yuki, Takafumi ; Taniguchi, Hideaki ; Aimi, Masahito ; Miyaoka, Yoichi ; Yuki, Mika ; Ishimura, Norihisa ; Oshima, Naoki ; Mishiro, Tsuyoshi ; Tamagawa, Yuji ; Mikami, Hironobu ; Izumi, Daisuke ; Yamashita, Noritsugu ; Sato, Shuichi ; Ishihara, Shunji ; Kinoshita, Yoshikazu</creatorcontrib><description>Background and Aim The esophageal triamcinolone acetonide (TA)‐filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential ESD. Methods We enrolled 20 patients with esophageal cancer requiring subcircumferential ESD in a prospective multicenter study. Esophageal TA filling was carried out 1 day and 1 week after ESD, with follow‐up endoscopy every 2 weeks. We treated severe stenosis preventing endoscope passage with endoscopic balloon dilatation (EBD) and additional TA filling, and mild stenosis allowing endoscope passage with additional TA filling only. Primary endpoint was incidence of severe stenosis; secondary endpoints were total number of EBD, rate of additional TA filling, time to stenosis and complete re‐epithelialization, dysphagia score, and adverse events. Horizontal resection grade was divided into grades 1 (≥ 9/12 and &lt;10/12 of the circumference), 2 (≥ 10/12 and &lt;11/12), and 3 (≥ 11/12 but not circumferential) and analyzed statistically for correlation with endpoints. Results Incidence of severe stenosis was 5.0% (1/20; 0.1–24.8%) and was treated with three EBD. Six patients showed mild stenosis. Additional TA filling was carried out in these seven patients: 0% (0/9) for grade 1 resection, 40% (2/5) for grade 2, and 83% (5/6) for grade 3 (P &lt; 0.05). Median time to stenosis and re‐epithelialization was 3 and 7 weeks, respectively. Dysphagia score deteriorated in one patient. No adverse events occurred. Conclusions The esophageal TA‐filling method prevented stenosis after subcircumferential ESD. Grade ≥2 resection showed a high risk for stenosis, but additional TA filling for mild stenosis inhibited stenosis progression (UMIN000024384).</description><identifier>ISSN: 0915-5635</identifier><identifier>EISSN: 1443-1661</identifier><identifier>DOI: 10.1111/den.13496</identifier><identifier>PMID: 31361925</identifier><language>eng</language><publisher>Australia</publisher><subject>Aged ; Aged, 80 and over ; Anti-Inflammatory Agents - administration &amp; dosage ; Carcinoma - pathology ; Carcinoma - surgery ; Endoscopic Mucosal Resection - adverse effects ; endoscopic submucosal dissection ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - surgery ; esophageal stenosis ; Esophageal Stenosis - epidemiology ; Esophageal Stenosis - prevention &amp; control ; Female ; Humans ; Male ; Middle Aged ; Postoperative Complications - epidemiology ; Postoperative Complications - prevention &amp; control ; prevention ; Prospective Studies ; Reproducibility of Results ; steroid ; triamcinolone acetonide ; Triamcinolone Acetonide - administration &amp; dosage</subject><ispartof>Digestive endoscopy, 2020-03, Vol.32 (3), p.355-363</ispartof><rights>2019 Japan Gastroenterological Endoscopy Society</rights><rights>2019 Japan Gastroenterological Endoscopy Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023</citedby><cites>FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fden.13496$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fden.13496$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31361925$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shibagaki, Kotaro</creatorcontrib><creatorcontrib>Yuki, Takafumi</creatorcontrib><creatorcontrib>Taniguchi, Hideaki</creatorcontrib><creatorcontrib>Aimi, Masahito</creatorcontrib><creatorcontrib>Miyaoka, Yoichi</creatorcontrib><creatorcontrib>Yuki, Mika</creatorcontrib><creatorcontrib>Ishimura, Norihisa</creatorcontrib><creatorcontrib>Oshima, Naoki</creatorcontrib><creatorcontrib>Mishiro, Tsuyoshi</creatorcontrib><creatorcontrib>Tamagawa, Yuji</creatorcontrib><creatorcontrib>Mikami, Hironobu</creatorcontrib><creatorcontrib>Izumi, Daisuke</creatorcontrib><creatorcontrib>Yamashita, Noritsugu</creatorcontrib><creatorcontrib>Sato, Shuichi</creatorcontrib><creatorcontrib>Ishihara, Shunji</creatorcontrib><creatorcontrib>Kinoshita, Yoshikazu</creatorcontrib><title>Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection</title><title>Digestive endoscopy</title><addtitle>Dig Endosc</addtitle><description>Background and Aim The esophageal triamcinolone acetonide (TA)‐filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential ESD. Methods We enrolled 20 patients with esophageal cancer requiring subcircumferential ESD in a prospective multicenter study. Esophageal TA filling was carried out 1 day and 1 week after ESD, with follow‐up endoscopy every 2 weeks. We treated severe stenosis preventing endoscope passage with endoscopic balloon dilatation (EBD) and additional TA filling, and mild stenosis allowing endoscope passage with additional TA filling only. Primary endpoint was incidence of severe stenosis; secondary endpoints were total number of EBD, rate of additional TA filling, time to stenosis and complete re‐epithelialization, dysphagia score, and adverse events. Horizontal resection grade was divided into grades 1 (≥ 9/12 and &lt;10/12 of the circumference), 2 (≥ 10/12 and &lt;11/12), and 3 (≥ 11/12 but not circumferential) and analyzed statistically for correlation with endpoints. Results Incidence of severe stenosis was 5.0% (1/20; 0.1–24.8%) and was treated with three EBD. Six patients showed mild stenosis. Additional TA filling was carried out in these seven patients: 0% (0/9) for grade 1 resection, 40% (2/5) for grade 2, and 83% (5/6) for grade 3 (P &lt; 0.05). Median time to stenosis and re‐epithelialization was 3 and 7 weeks, respectively. Dysphagia score deteriorated in one patient. No adverse events occurred. Conclusions The esophageal TA‐filling method prevented stenosis after subcircumferential ESD. Grade ≥2 resection showed a high risk for stenosis, but additional TA filling for mild stenosis inhibited stenosis progression (UMIN000024384).</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Inflammatory Agents - administration &amp; dosage</subject><subject>Carcinoma - pathology</subject><subject>Carcinoma - surgery</subject><subject>Endoscopic Mucosal Resection - adverse effects</subject><subject>endoscopic submucosal dissection</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - surgery</subject><subject>esophageal stenosis</subject><subject>Esophageal Stenosis - epidemiology</subject><subject>Esophageal Stenosis - prevention &amp; control</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - prevention &amp; control</subject><subject>prevention</subject><subject>Prospective Studies</subject><subject>Reproducibility of Results</subject><subject>steroid</subject><subject>triamcinolone acetonide</subject><subject>Triamcinolone Acetonide - administration &amp; dosage</subject><issn>0915-5635</issn><issn>1443-1661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kcFuFSEUhonR2NvqwhcwLHUx7QADU5amVmvStF3oeoKHQy-GgXFgbO7OR_AxfC6fRMZbGzeyOCQnH18O5yfkBWuPWT0nFuMxE51Wj8iGdZ1omFLsMdm0mslGKiEPyGHOX9qWcd11T8mBYEIxzeWG_LyZU54Qiv-GdFxC8YCx4ExzWeyOJkfLFinmNG3NLZpAy-zNCD6mkCJSA1hS9BZ_ff_hfAg-3tIRyzZZ6iOdTPHVlumdL1ual8_gZ1hGh3Pt-ir7x4vRpgxp8rCC4wIp1671Oa_DpfiMPHEmZHx-fx-RT-_OP55dNJfX7z-cvblsYF1Aw512pwY406rlguMpgJa670UvpBMOnJEKmTbM1uJ6roXsraxFgWuhPjkir_beaU5fF8xlGH0GDMFETEseOFd91yrWr-jrPQp1h3lGN0yzH828G1g7rMEMNZjhTzCVfXmvrZ9D-0D-TaICJ3vgzgfc_d80vD2_2it_A993ngA</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Shibagaki, Kotaro</creator><creator>Yuki, Takafumi</creator><creator>Taniguchi, Hideaki</creator><creator>Aimi, Masahito</creator><creator>Miyaoka, Yoichi</creator><creator>Yuki, Mika</creator><creator>Ishimura, Norihisa</creator><creator>Oshima, Naoki</creator><creator>Mishiro, Tsuyoshi</creator><creator>Tamagawa, Yuji</creator><creator>Mikami, Hironobu</creator><creator>Izumi, Daisuke</creator><creator>Yamashita, Noritsugu</creator><creator>Sato, Shuichi</creator><creator>Ishihara, Shunji</creator><creator>Kinoshita, Yoshikazu</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202003</creationdate><title>Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection</title><author>Shibagaki, Kotaro ; Yuki, Takafumi ; Taniguchi, Hideaki ; Aimi, Masahito ; Miyaoka, Yoichi ; Yuki, Mika ; Ishimura, Norihisa ; Oshima, Naoki ; Mishiro, Tsuyoshi ; Tamagawa, Yuji ; Mikami, Hironobu ; Izumi, Daisuke ; Yamashita, Noritsugu ; Sato, Shuichi ; Ishihara, Shunji ; Kinoshita, Yoshikazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Inflammatory Agents - administration &amp; dosage</topic><topic>Carcinoma - pathology</topic><topic>Carcinoma - surgery</topic><topic>Endoscopic Mucosal Resection - adverse effects</topic><topic>endoscopic submucosal dissection</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - surgery</topic><topic>esophageal stenosis</topic><topic>Esophageal Stenosis - epidemiology</topic><topic>Esophageal Stenosis - prevention &amp; control</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - prevention &amp; control</topic><topic>prevention</topic><topic>Prospective Studies</topic><topic>Reproducibility of Results</topic><topic>steroid</topic><topic>triamcinolone acetonide</topic><topic>Triamcinolone Acetonide - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shibagaki, Kotaro</creatorcontrib><creatorcontrib>Yuki, Takafumi</creatorcontrib><creatorcontrib>Taniguchi, Hideaki</creatorcontrib><creatorcontrib>Aimi, Masahito</creatorcontrib><creatorcontrib>Miyaoka, Yoichi</creatorcontrib><creatorcontrib>Yuki, Mika</creatorcontrib><creatorcontrib>Ishimura, Norihisa</creatorcontrib><creatorcontrib>Oshima, Naoki</creatorcontrib><creatorcontrib>Mishiro, Tsuyoshi</creatorcontrib><creatorcontrib>Tamagawa, Yuji</creatorcontrib><creatorcontrib>Mikami, Hironobu</creatorcontrib><creatorcontrib>Izumi, Daisuke</creatorcontrib><creatorcontrib>Yamashita, Noritsugu</creatorcontrib><creatorcontrib>Sato, Shuichi</creatorcontrib><creatorcontrib>Ishihara, Shunji</creatorcontrib><creatorcontrib>Kinoshita, Yoshikazu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shibagaki, Kotaro</au><au>Yuki, Takafumi</au><au>Taniguchi, Hideaki</au><au>Aimi, Masahito</au><au>Miyaoka, Yoichi</au><au>Yuki, Mika</au><au>Ishimura, Norihisa</au><au>Oshima, Naoki</au><au>Mishiro, Tsuyoshi</au><au>Tamagawa, Yuji</au><au>Mikami, Hironobu</au><au>Izumi, Daisuke</au><au>Yamashita, Noritsugu</au><au>Sato, Shuichi</au><au>Ishihara, Shunji</au><au>Kinoshita, Yoshikazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection</atitle><jtitle>Digestive endoscopy</jtitle><addtitle>Dig Endosc</addtitle><date>2020-03</date><risdate>2020</risdate><volume>32</volume><issue>3</issue><spage>355</spage><epage>363</epage><pages>355-363</pages><issn>0915-5635</issn><eissn>1443-1661</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-1</notes><notes>content type line 23</notes><abstract>Background and Aim The esophageal triamcinolone acetonide (TA)‐filling method is a novel local approach for stenosis prevention after extensive esophageal endoscopic submucosal dissection (ESD). We evaluated this method after subcircumferential ESD. Methods We enrolled 20 patients with esophageal cancer requiring subcircumferential ESD in a prospective multicenter study. Esophageal TA filling was carried out 1 day and 1 week after ESD, with follow‐up endoscopy every 2 weeks. We treated severe stenosis preventing endoscope passage with endoscopic balloon dilatation (EBD) and additional TA filling, and mild stenosis allowing endoscope passage with additional TA filling only. Primary endpoint was incidence of severe stenosis; secondary endpoints were total number of EBD, rate of additional TA filling, time to stenosis and complete re‐epithelialization, dysphagia score, and adverse events. Horizontal resection grade was divided into grades 1 (≥ 9/12 and &lt;10/12 of the circumference), 2 (≥ 10/12 and &lt;11/12), and 3 (≥ 11/12 but not circumferential) and analyzed statistically for correlation with endpoints. Results Incidence of severe stenosis was 5.0% (1/20; 0.1–24.8%) and was treated with three EBD. Six patients showed mild stenosis. Additional TA filling was carried out in these seven patients: 0% (0/9) for grade 1 resection, 40% (2/5) for grade 2, and 83% (5/6) for grade 3 (P &lt; 0.05). Median time to stenosis and re‐epithelialization was 3 and 7 weeks, respectively. Dysphagia score deteriorated in one patient. No adverse events occurred. Conclusions The esophageal TA‐filling method prevented stenosis after subcircumferential ESD. Grade ≥2 resection showed a high risk for stenosis, but additional TA filling for mild stenosis inhibited stenosis progression (UMIN000024384).</abstract><cop>Australia</cop><pmid>31361925</pmid><doi>10.1111/den.13496</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0915-5635
ispartof Digestive endoscopy, 2020-03, Vol.32 (3), p.355-363
issn 0915-5635
1443-1661
language eng
recordid cdi_proquest_miscellaneous_2267406172
source Wiley-Blackwell Journals
subjects Aged
Aged, 80 and over
Anti-Inflammatory Agents - administration & dosage
Carcinoma - pathology
Carcinoma - surgery
Endoscopic Mucosal Resection - adverse effects
endoscopic submucosal dissection
Esophageal Neoplasms - pathology
Esophageal Neoplasms - surgery
esophageal stenosis
Esophageal Stenosis - epidemiology
Esophageal Stenosis - prevention & control
Female
Humans
Male
Middle Aged
Postoperative Complications - epidemiology
Postoperative Complications - prevention & control
prevention
Prospective Studies
Reproducibility of Results
steroid
triamcinolone acetonide
Triamcinolone Acetonide - administration & dosage
title Prospective multicenter study of the esophageal triamcinolone acetonide‐filling method in patients with subcircumferential esophageal endoscopic submucosal dissection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T23%3A39%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20multicenter%20study%20of%20the%20esophageal%20triamcinolone%20acetonide%E2%80%90filling%20method%20in%20patients%20with%20subcircumferential%20esophageal%20endoscopic%20submucosal%20dissection&rft.jtitle=Digestive%20endoscopy&rft.au=Shibagaki,%20Kotaro&rft.date=2020-03&rft.volume=32&rft.issue=3&rft.spage=355&rft.epage=363&rft.pages=355-363&rft.issn=0915-5635&rft.eissn=1443-1661&rft_id=info:doi/10.1111/den.13496&rft_dat=%3Cproquest_cross%3E2267406172%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3496-2f9f8ac21960232e8cc959773735f3fcfa56e19a1d19af729357d53576cf0c023%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2267406172&rft_id=info:pmid/31361925&rfr_iscdi=true